Literature DB >> 17219265

Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks.

Yasuhiro Ito1, Akira Miyauchi.   

Abstract

BACKGROUND: There are 3 compartments of regional lymph nodes to which thyroid carcinoma metastasizes: central, lateral, and mediastinal compartments. The central compartment is the nearest to the thyroid and usually dissected routinely. However, the indication for dissection of the lateral and mediastinal compartments for differentiated thyroid carcinoma remains an open question.
METHODS: The indication for dissection of lateral and mediastinal compartments is evaluated based on previous reports, including those from our department.
RESULTS: There is nothing controversial about the indication for therapeutic lateral node dissection for tumors with clinically apparent lateral node metastasis. Such cases are more likely to show recurrence, especially in previously dissected compartments, and surgeons must perform dissection carefully. Although there are no randomized studies on the indication for prophylactic lateral node dissection, it is recommended for papillary carcinoma with aggressive characteristics such as large size and massive extrathyroid extension. Prophylactic mediastinal dissection via median sternotomy is not recommended.
CONCLUSIONS: Node dissection of the lateral and mediastinal compartments must be performed aggressively and radically to prevent recurrence in previously dissected regions.

Entities:  

Mesh:

Year:  2007        PMID: 17219265     DOI: 10.1007/s00268-006-0722-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  69 in total

1.  Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.

Authors:  Catharina Ihre Lundgren; Per Hall; Paul W Dickman; Jan Zedenius
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

2.  Accurate and simple method of diagnosing thyroid nodules the modified technique of ultrasound-guided fine needle aspiration biopsy.

Authors:  T Yokozawa; A Miyauchi; K Kuma; M Sugawara
Journal:  Thyroid       Date:  1995-04       Impact factor: 6.568

3.  Selection of surgical treatment for well differentiated thyroid carcinomas.

Authors:  J A Buckwalter; C G Thomas
Journal:  Ann Surg       Date:  1972-10       Impact factor: 12.969

4.  Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma.

Authors:  Yasuhiro Ito; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

5.  Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma.

Authors:  H W Mueller-Gaertner; H T Brzac; W Rehpenning
Journal:  Cancer       Date:  1991-04-01       Impact factor: 6.860

6.  Neck dissection for surgical treatment of lymphnode metastasis in papillary thyroid carcinoma.

Authors:  M Ducci; M Appetecchia; M Marzetti
Journal:  J Exp Clin Cancer Res       Date:  1997-09

7.  Clinical evaluation of upper mediastinal dissection for differentiated thyroid carcinoma.

Authors:  A Sugenoya; K Asanuma; K Shingu; H Onuma; T Shimizu; H Masuda; Y Kasuga; S Kobayashi; F Iida
Journal:  Surgery       Date:  1993-05       Impact factor: 3.982

8.  Safety of modified radical neck dissection for differentiated thyroid carcinoma.

Authors:  Michael E Kupferman; D Michael Patterson; Susan J Mandel; Virginia LiVolsi; Randal S Weber
Journal:  Laryngoscope       Date:  2004-03       Impact factor: 3.325

9.  Multifactorial study of prognostic factors in differentiated thyroid carcinoma and a re-evaluation of the importance of age.

Authors:  F Bacourt; B Asselain; J C Savoie; E D'Hubert; J P Massin; G Doucet; A Leger; H Garnier
Journal:  Br J Surg       Date:  1986-04       Impact factor: 6.939

10.  Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid.

Authors:  Y Ito; H Yoshida; K Nakano; K Kobayashi; T Yokozawa; K Hirai; F Matsuzuka; N Matsuura; K Kakudo; K Kuma; A Miyauchi
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640

View more
  19 in total

1.  Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection.

Authors:  Yasuhiro Ito; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2007-11       Impact factor: 3.352

2.  Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma.

Authors:  Yang Guang; Yukun Luo; Yan Zhang; Mingbo Zhang; Nan Li; Ying Zhang; Jie Tang
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-24       Impact factor: 4.553

3.  Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection.

Authors:  Yasuhiro Ito; Takumi Kudo; Yuuki Takamura; Kaoru Kobayashi; Akihiro Miya; Akira Miyauchi
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

Review 4.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

5.  Significance of prophylactic modified radical neck dissection for patients with low-risk papillary thyroid carcinoma measuring 1.1-3.0 cm: first report of a trial at Kuma Hospital.

Authors:  Yasuhiro Ito; Yukiko Tsushima; Hiroo Masuoka; Tomonori Yabuta; Mitsuhiro Fukushima; Hiroyuki Inoue; Chisato Tomoda; Minoru Kihara; Takuya Higashiyama; Yuuki Takamura; Kaoru Kobayashi; Akihiro Miya; Akira Miyauchi
Journal:  Surg Today       Date:  2011-10-04       Impact factor: 2.549

6.  Risk factors for lateral cervical lymph node involvement in follicular thyroid carcinoma.

Authors:  Haitham Alfalah; Isaac Cranshaw; Thomas Jany; Laurent Arnalsteen; Emmanuelle Leteurtre; Catherine Cardot; François Pattou; Bruno Carnaille
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

Review 7.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

Review 8.  Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

Review 9.  Thyroid ultrasonography.

Authors:  Yasuhiro Ito; Nobuyuki Amino; Akira Miyauchi
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

10.  Is routine dissection of level II-B and V-A necessary in patients with papillary thyroid cancer undergoing lateral neck dissection for FNA-confirmed metastases in other levels.

Authors:  Tarik Farrag; Frank Lin; Noel Brownlee; Matthew Kim; Sheila Sheth; Ralph P Tufano
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.